Location History:
- Miramar, FL (US) (2011 - 2013)
- Southwest Ranches, FL (US) (2012 - 2014)
Company Filing History:
4 out of 3,539 
3 out of 1,974 
Years Active: 2011-2014
Title: Gagani P Athauda: Innovator in Cancer Research
Introduction
Gagani P Athauda is a notable inventor based in Miramar, FL (US). He has made significant contributions to the field of cancer research, holding a total of 4 patents. His work focuses on innovative methods and compositions that aim to improve cancer diagnosis and treatment.
Latest Patents
Athauda's latest patents include groundbreaking research on compositions and methods for inhibiting hepatocyte growth factor receptor c-Met signaling. This includes derivatives and analogs of inhibitors of receptor tyrosine kinase c-Met, along with pharmaceutical compositions containing these derivatives and analogs. Additionally, he has developed methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain. His methods for measuring c-Met levels in urine and blood samples provide valuable tools for cancer diagnosis and prognosis evaluation.
Career Highlights
Throughout his career, Athauda has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Amgen Inc. His experience in these institutions has allowed him to contribute significantly to advancements in medical research and innovation.
Collaborations
Some of Athauda's notable coworkers include Donald P Bottaro and Teresa Lynn Burgess. Their collaborative efforts have further enhanced the impact of his research in the field of cancer treatment.
Conclusion
Gagani P Athauda's innovative work in cancer research exemplifies the importance of scientific advancements in improving patient outcomes. His contributions through patents and collaborations continue to pave the way for future discoveries in the medical field.